
Overview
Dr. Juan Carlos Varela is a board-certified and fellowship-trained physician specializing in hematology and oncology with the Bone Marrow Transplant and Cellular Therapy program at the Orlando Health Cancer Institute. He previously served as medical director of a Blood and Marrow Transplant/Cellular Therapy program in Orlando and most recently was medical director for Outpatient Services and led the Acute Leukemia and Bone Marrow Transplant Program in the Division of Hematological Malignancies in Boston. His services include: Bone marrow transplants (autologous, allogeneic, cord blood and haploidentical) Bispecific antibodies CAR-T cell therapy Acute leukemia myelodysplastic syndrome treatment Cellular therapy lab (on-site collection facility and cell manipulation) Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma, graft versus host disease and lung transplant rejection Clinical trials Dr. Varela takes his patients’ specific goals and needs into account in order to treat each patient as an individual, rather than taking a blanket approach to treating the disease. Dr. Varela’s Training Dr. Varela earned his medical degree and doctorate from the Medical University of South Carolina in Charleston. He completed an internal medicine residency and hematology fellowship at The Johns Hopkins Hospital in Baltimore. About Dr. Varela Dr. Varela is certified in hematology and internal medicine with the American Board of Internal Medicine. He is a member of the American Society for Transplantation and Cellular Therapy and American Society of Hematology. Dr. Varela is a physician scientist and has been the principal investigator in dozens of clinical trials for cellular therapy, hematologic malignancies and bone marrow transplants. He has successfully translated novel immunotherapeutic approaches from the bench to the bedside and has been the leader in multiple first-in-human studies of novel T-cell therapies in hematologic malignancies. His research has been published extensively in peer-reviewed publications on topics including hematopoietic stem cell transplantation, acute myelogenous leukemia and adoptive T cell immunotherapy. Outside of work, Dr. Varela enjoys music, sports and spending time with his family. He is fluent in English and Spanish.
Dr. Varela is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.
Dr. Varela is board certified in American Board Of Internal Medicine - Hematology and American Board Of Internal Medicine - Internal Medicine. He is actively involved in clinical research, co-authoring 29 peer reviewed articles and participating in 8 clinical trials.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1400 S. Orange Ave., Orlando, FL 32806
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Florida Cancer Specialists & Research Institute, LLC
Sonalee Shroff is a Hematologist and an Oncologist practicing medicine in Winter Park, Florida. Dr. Shroff is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Shroff is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Juan C. Varela
How do I make an appointment with Dr. Juan C. Varela?
You can book an appointment with Dr. Juan C. Varela by calling their office at 321-841-1869. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Juan C. Varela a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Juan C. Varela is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Juan C. Varela specialize in?
While Dr. Juan C. Varela is a Transplant Surgery, they have specific expertise in Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Acute Myeloblastic Leukemia without Maturation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Transplant Surgery.
Does Dr. Juan C. Varela participate in research or clinical trials?
Yes. Dr. Juan C. Varela has published 29 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Juan C. Varela's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Juan C. Varela accept my insurance?
Dr. Juan C. Varela accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 321-841-1869 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia with MaturationDr. Varela isDistinguished. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Varela isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Childhood Acute Myeloid LeukemiaDr. Varela isDistinguished. Learn about Childhood Acute Myeloid Leukemia.
- Advanced
- Bone Marrow AspirationDr. Varela isAdvanced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Varela isAdvanced. Learn about Bone Marrow Transplant.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Graft Versus Host Disease (GvHD)Dr. Varela isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Large-Cell Immunoblastic LymphomaDr. Varela isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukemiaDr. Varela isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Varela isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Varela isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Promyelocytic LeukemiaDr. Varela isExperienced. Learn about Acute Promyelocytic Leukemia.
- AgranulocytosisDr. Varela isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Varela isExperienced. Learn about Aplastic Anemia.
- B-Cell LymphomaDr. Varela isExperienced. Learn about B-Cell Lymphoma.

